Life Experience Committee presentation to the NAIC Life Actuarial (A) Task Force on joint committee recommended changes related to guaranteed issue (GI) tables, and exposed simplified issue (SI) exposed tables and report. (
)
The C2 Life Mortality RBC Work Group presentation on their work reviewing the C2 RBC requirement for life insurance to the NAIC’s Life Risk Based Capital Working Group.
Annuity Reserves Work Group presentation on its work related to issues that need to be modified for non-variable annuities to the Life Actuarial Task Force. (
)
Standard Valuation Law Interest Rate Modernization Work Group presentation to the NAIC's Life Actuarial Task Force (LATF) summarizing its activities on its new project to modernize the process of setting valuation interest rates for non-variable annuities (except SPIAs).
(
)
Mary Bahna-Nolan, chairperson of the Academy's Life Experience Committee and SOA Preferred Mortality Oversight Group, presentation on the guaranteed issue report and amendment proposals to the Life Actuarial Task Force. (
)
Mary Bahna-Nolan, chairperson of the Academy's Life Experience Committee and SOA Preferred Mortality Oversight Group, presentation on the 2017 simplified issue composite mortality tables to the Life Actuarial Task Force. (
)
Mary Bahna-Nolan, chairperson of the Academy's Life Experience Committee and SOA Preferred Mortality Oversight Group, presentation on PBR valuation considerations and recommendations related to accelerated underwriting to the Life Actuarial Task Force. (
)
Tricia Matson, chairperson of the Longevity Risk Task Force, gave a presentation to the NAIC's Life Risk-Based Capital (RBC) Working Group regarding the development of a methodology for recognizing longevity risk in statutory reserves and RBC. (
)
Mary Bahna-Nolan, chairperson of the Academy’s Life Experience Committee and SOA Preferred Mortality Oversight Group, presented an update on the joint committee’s work to address the Life Actuarial Task Force (LATF) request for information on simplified issue and accelerated underwriting mortality under VM-20. (
)